CAV1 and renal cell carcinoma: We hypothesise that caveolin-1 acts synergistically with the AKT/mTOR pathway in RCC leading to disease progression, and that this molecularly linked signature represents a powerful prognostic determinant for identifying subsets of patients with higher probability of recurrence and metastatic spread.